Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore!   Learn More →
← Back to all trials
Not Yet Recruiting NCT05685914

Outcomes of Endoscopic Operation in COVID-19 Infection: Cohort Study.

Conditions: COVID-19, Surgery-Complications

Sex: All
Ages: 18 Years – 90 Years
Enrollment: 200
Sponsor: Peking University Cancer Hospital & Institute

Location: China

Summary

The goal of this observational study is to determine 30-day mortality and post endoscopic surgery complications in patients with COVID-19 infection who undergo endoscopic surgery.This results will inform future risk stratification, decision making and improve patient's clinical care.This study is an investigator-led, non-commercial, non-interventional study is extremely low risk, or even zero risk.

Eligibility Criteria

Inclusion Criteria:Patients undergoing any type of endoscopic surgery in an operating theatre and these patients had COVID-19 infection either at the time of surgery or within 30 days of surgery.Exclusion Criteria:If COVID-19 infection is diagnosed >30 days after discharge, the patient should not be included.

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT05685914). StuddyBuddy aggregates publicly available trial information.